http://rdf.ncbi.nlm.nih.gov/pubchem/reference/36257518

Outgoing Links

Predicate Object
contentType Journal Article
issn 2405-8440
issueIdentifier 11
pageRange e22222-
publicationName Heliyon
startingPage e22222
hasFundingAgency http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_99902231d65077b0520df21188fa112b
http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_d6290f42971f1bda976ae690ad000f99
bibliographicCitation Yin Z, Li ZF, Zhang WJ, Zhang S, Sui YG, Xu YL, Zhang HT, Liu XN, Qiu H, Zhao JL, Li JJ, Dou KF, Qian J, Wu YJ, Wu NQ; PIECES-OCT investigators. Rationale and design of a randomized controlled trial: The effect of intensive lipid-lowering therapy with PCSK9 inhibitor on endothelial-coverage of stent strut after percutaneous coronary intervention (PCI) for patients with acute coronary syndrome (ACS): Optical coherence tomography (OCT) study (PIECES-OCT study). Heliyon. 2023 Nov;9(11):e22222. PMID: 38045163; PMCID: PMC10689873.
creator http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_57897bd5eccf4c5c08721aa36b67e93f
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_943a7d646d5d108f1c44b4279953d742
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_29c9f7d5709684134b9b41a4316eedb0
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_6c9e6242e46da45ee6f137ba0ae096c7
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_ad97210d57d6735c7a9ee1fac8c731e8
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_02fd8c331a82a8af3113a9c1241b283d
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_d6a2a719c0b7939bf3b83a666f9f1857
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_cfd94760620c439ee5f533f23de6f1e0
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_4a1b517d48c0674eb37718517908efd3
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_dafb1c67df0dd827650081ed94162eaf
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_1be7608f73e94e744540d5621bc45705
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_fdfbb9a666b28fda98300f4624e94240
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_b0731eea4be18b9d8eae72a589dc751b
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_e87d9a4afb52eec854e1215b8c8bdc6f
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_215254cd129abafc5f0d5bf229b7b20b
date 202311
identifier https://pubmed.ncbi.nlm.nih.gov/PMC10689873
https://pubmed.ncbi.nlm.nih.gov/38045163
https://doi.org/10.1016/j.heliyon.2023.e22222
isPartOf https://portal.issn.org/resource/ISSN/2405-8440
http://rdf.ncbi.nlm.nih.gov/pubchem/journal/44637
language English
source https://pubmed.ncbi.nlm.nih.gov/
https://www.crossref.org/
title Rationale and design of a randomized controlled trial: The effect of intensive lipid-lowering therapy with PCSK9 inhibitor on endothelial-coverage of stent strut after percutaneous coronary intervention (PCI) for patients with acute coronary syndrome (ACS): Optical coherence tomography (OCT) study (PIECES-OCT study)

Showing number of triples: 1 to 34 of 34.